Skip to Content

Zylkene 225 mg (Canada)

This page contains information on Zylkene 225 mg for veterinary use.
The information provided typically includes the following:
  • Zylkene 225 mg Indications
  • Warnings and cautions for Zylkene 225 mg
  • Direction and dosage information for Zylkene 225 mg

Zylkene 225 mg

This treatment applies to the following species:
Company: Vetoquinol

Alpha-S1 Tryptic Casein

FOR DOGS

Veterinary Health Product

PALATABLE

NN.13XZ

Keep out of reach of children

Purpose

Promotes and enhances relaxed behaviour in pets. Alpha-S1 Tryptic Casein*, also called alpha-casozepine, is an ingredient derived from a milk protein which has calming properties.

Learning new behaviours is easier in a relaxed animal.

Directions For Use

Body weight of animal

Recommended daily dose Zylkene® 225 mg

10-15 kg

1 capsule

15-30 kg

2 capsules

The capsules can be administered orally as a single dose, whole or opened (mix the powder with the meal or with a delicacy). Respect the veterinarian’s recommendation.

Short term use: Use for 1-2 days before the predicted event or change in environment. Some animals may need earlier administration (5-7 days).

Longer term use: 1-2 months.

Storage Conditions

Store in a cool and dry place. Close well after each use.

For questions or to report a side effect: 1 800 363-1700

*Patented bioactive peptide

Vetoquinol N.-A. Inc., 2000, ch. Georges, Lavaltrie, QC, Canada J5T 3S5

www.vetoquinol.ca

Net

Code

 

30 capsules

425110

456313 0418 C

CPN: 1234356.4

VETOQUINOL N.-A. INC.
Commercial Division

2000, CHEMIN GEORGES, LAVALTRIE, QC, J5T 3S5
Telephone:   450-586-2252
Order Desk:   800-363-1700
Fax:   450-586-4649
Website:   www.vetoquinol.ca
Email:   info@vetoquinol.ca
Every effort has been made to ensure the accuracy of the Zylkene 225 mg information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2020 Animalytix LLC. Updated: 2020-10-21